N-a-acetyltransferase 10 protein, Naa10p, is an N-acetyltransferase known to be involved in cell cycle control. We found that Naa10p was expressed lower in varieties of malignancies with lymph node metastasis compared with non-lymph node metastasis. Higher Naa10p expression correlates the survival of lung cancer patients. Naa10p significantly suppressed migration, tumor growth, and metastasis independent of its enzymatic activity. Instead, Naa10p binds to the GIT-binding domain of PIX, thereby preventing the formation of the GIT-PIX-Paxillin complex, resulting in reduced intrinsic Cdc42/Rac1 activity and decreased cell migration. Forced expression of PIX in Naa10-transfected tumor cells restored the migration and metastasis ability. We suggest that Naa10p functions as a tumor metastasis suppressor by disrupting the migratory complex, PIX-GIT-Paxillin, in cancer cells.
INTRODUCTION
N-a-acetyltransferase 10 (Naa10, also known as ARD1) protein is the catalytic subunit of the major N-terminal acetyltransferase (NAT) complex, NatA, consisting of Naa10p and human Naa15p (also known as NATH). Together, they mediate the N-terminal acetylation of nascent polypeptides that emerge from ribosomes after translation (Arnesen et al., 2009 ). The specificity of Naa10p is highly conserved from yeasts to humans (Arnesen et al., 2005 (Arnesen et al., , 2009 Park and Szostak, 1992; Whiteway and Szostak, 1985) . Ard1-D yeast mutants and Naa10p knockdown cells show a similar defect in cell growth (Fisher et al., 2005; Lim et al., 2006; Whiteway and Szostak, 1985) . Recently, Naa10p expression was reported in breast, cervical, thyroid, and colorectal
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cancer (Fluge et al., 2002; Ren et al., 2008; Yu et al., 2009 ). However, the correlation between Naa10p and important clinical parameters, as well as the exact action of Naa10p in cancer cells remain unclear.
During cell migration, actin filaments organize into a branched network at the leading edge, and the filaments undergo rapid and coordinated assembly and/or disassembly to drive the edge forward (Pollard and Borisy, 2003) . The concerted regulation of these events is mediated by a complex temporal and spatial interplay of Rho GTPases and their regulatory proteins, including guanine nucleotide exchange factors (GEFs), GTPase-activating proteins (GAPs), and guanine nucleotide dissociation inhibitors (GDIs) (Gulli and Peter, 2001 ). The p21-activated kinase (PAK)-interacting exchange factor (PIX) family members have been shown to act as GEFs mediating the activation of Rac1 and Cdc42. In addition, PIX proteins can serve as scaffold proteins by binding to Paxillin and G proteincoupled receptor kinase-interacting (GIT) proteins, the GAP for Arf GTPases, resulting in translocation of the GIT-PIX-Paxillin complex to a focal adhesion complex and membrane ruffles (Botrugno et al., 2006; Hoefen and Berk, 2006; Webb et al., 2002) . The PIX complex serves as a multifunctional protein binding platform that plays an important role in the control of cell shape, polarity, and focal adhesion turnover (Frank and Hansen, 2008; Hoefen and Berk, 2006; Jones and Katan, 2007; Zhang et al., 2005) . PIX proteins were found to be highly expressed in glioma (Yokota et al., 2006) and breast cancer (Ahn et al., 2003) . Both PIX and GIT were found to increase the migration potentials of a variety of cancer cells (Lee et al., 2005; Manabe et al., 2002) . Recently, the GEF activity of PIX was found to be regulated by phosphorylation at specific sites and its binding interactions (Chahdi et al., 2005; Shin et al., 2002 Shin et al., , 2004 . Binding of PAK and GTP-bound Cdc42 stimulates aPIX GEF activity (Baird et al., 2005; Feng et al., 2004) , while binding of 14-3-3b inhibits bPIX GEF activity (Chahdi and Sorokin, 2008) . Nonetheless, the regulation of PIX localization and the formation of the PIX-GIT-Paxillin complex remain unknown.
Here, we investigated whether Naa10p expressed differentially in tumors of different progression status and the involvement of Naa10p in the regulation of PIX-GIT complex formation and function.
RESULTS

Expression of Naa10p Inversely Correlates with Lymph Node Metastasis and Survival of Cancer Patients
To elucidate the clinical relevance of Naa10p in cancer patients, we analyzed a cohort of 318 lung cancer specimens using immunohistochemical analysis (IHC) with Naa10p-specific antibody. The antibody specificity was defined and is shown in Figure S1A available online. Naa10p expression was detected in normal lung epithelium ( Figure 1A ), lung adenocarcinomas (Figures 1B and 1C) , and in squamous cell carcinomas ( Figures 1D and 1E ). Naa10p was found to be expressed predominantly in the cytosol, and rarely in the nucleus. Naa10p expression was inversely correlated with lymph node metastasis (Table 1) . Semiquantitative analysis by immunoblotting of an independent cohort of lung adenocarcinoma (N = 89) also confirms this correlation ( Figure 1F ). To study the significance of Naa10p in lymph node metastasis, we collected 15 sets of individually matched samples from primary tumors and lymph node metastases. Strikingly, in 13 out of 15 patients, the Naa10p levels were significantly reduced in the lymph node metastatic tumors compared with primary lung tumors (Figures 1G and 1H, p < 0.01) . Notably, the early stage tumor without lymph node involvement had the highest level of Naa10p expression (case 1 in Figure 1G ). Similar results were also found in breast (n = 53) and gastric cancer tissues (n = 92) by comparing patients with or without lymph node metastasis (Figures S1E to S1G). Naa10p expression was significantly correlated with both relapse-free survival and overall survival of lung cancer patients ( Figure 1I ; Figures S1B-S1D). Taken together, the above clinical data indicate that downregulation of Naa10p is a critical event in tumor progression.
Naa10p Suppresses Mobility of Cancer Cells
Our clinical findings suggest that Naa10p may play a role in the invasiveness and metastatic ability of tumor cells. We next evaluated the function of Naa10p in cell migration, which is the most fundamental step of tumor invasion and metastasis. siRNAs knockdown of Naa10p significantly increased cell motility in lung cancer cell lines with limited transwell migration ability (CL1-0, H661, PC14, and H1435) (Figure 2A ; Figure S2A ). To exclude the possibility of off-target effects, we reintroduced Naa10p in to the cells, bringing the migration level back to normal ( Figure 2B ). In comparison, overexpression of Naa10p significantly decreased cell migration in highly migratory lung cancer cell lines CL1-5, H1355, and A549 ( Figure 2C ). These results were also confirmed in a series of breast, ovarian, and gastric cancer cell lines (Figures S2B). Similar results were obtained in cell tracking assays ( Figure S2C ). Naa10p affected the invasion ability and migration of cancer cells to a similar extent (Figure S2D ). However, we did not detect any significant difference in matrix metalloproteinase levels among these cells (data not shown). Thus, the effect of Naa10p on cell invasiveness was largely attributable to migration inhibition. In addition, manipulation of Naa10p expression had no significant effect on cell proliferation ( Figure S2E ). Furthermore, the distribution of focal adhesions was altered in the Naa10p-knockdown AGS cells as detected by paxillin-specific antibody. The control AGS cells displayed an immotile phenotype with random distribution of paxillin around the cell, while most of the Naa10p-knockdown cells displayed one or more pseudopodia-like membrane protrusions, which may explain the increase in migration ability. The control CL1-5 cells had most of their focal adhesions in the puncta of membrane protrusions, while Naa10p-expressing cells displayed a more random distribution ( Figure 2D ). Taken together, these results indicate Naa10p plays important roles in cell migration.
Acetyltransferase Activity of Naa10p Is Not Necessary for Regulating Cell Migration Naa10p exerts its acetyltransferase activity through collaboration with Naa15p (Arnesen et al., 2005) . To determine whether Naa10p affects cell migration in a Naa15p-dependent manner, we cotransfected Naa10p and Naa15p into A549 cells and measured their relative migration abilities. Comparing to the known cooperative role of Naa10p and Naa15p in other cellular functions (Arnesen et (I) Kaplan-Meier plot of overall and disease-free survival of 318 patients with lung carcinomas stratified by Naa10p expression level. A log rank test was used to show differences between groups. See also Figure S1 . Lim et al., 2006) , Naa10p-mediated suppression of migration was not accelerated in the presence of Naa15p ( Figure 2E , column 4 versus column 2). To confirm whether the acetylation activity of Naa10p was involved in regulating cell mobility, we generated a mutant Naa10p construct, Naa10p-R82A, which had lost its ability to associate with acetyl-CoA, and therefore exhibited low acetyltransferase activity (Asaumi et al., 2005 ) as confirmed by [ 3 H]-acetate incorporation assay using PCNP, a known Naa10p N-acetylation target (Arnesen et al., 2009) , as substrate ( Figure S2F ). Interestingly, no difference in the migration ability was detectable between Naa10p-and Naa10p-R82A-transfected A549 cells ( Figure 2E ). Similarly, overexpression or shRNA inhibition of Naa11p, a homolog of Naa10p that displays similar acetyltransferase activity, did not affect cell migration (Figures 2F and 2G) . Taken together, these results suggest that Naa10p regulates cell migration through a mechanism independent of Naa15p and its intrinsic acetyltransferase activity.
Suppression of Tumor Growth and Metastasis by Naa10p
We next examined the in vivo effects of Naa10p expression on tumor growth and metastasis. Control CL1-5 cells (CL1-5/vec) subcutaneously injected into NOD-SCID mice formed large tumors after 4 weeks. In contrast, mice injected with CL1-5 cells ectopically expressing Naa10p (CL1-5/Naa10) or Naa10p-R82A (CL1-5/R82A) grew small tumors ( Figure S3A ). The ability of these tumors to retain the expression of Naa10p or Naa10p-R82A was examined ( Figure S3B ). No metastases were macroscopically visible in the lungs of these mice; longer monitoring times would be needed to observe such secondary tumors. However, the mice had to be sacrificed after 4 weeks due to large subcutaneous tumors according to the guidelines of the Animal Ethic Committee. To circumvent this problem, we isolated cells from the lung tissue at the endpoint of the study and cultured them in the presence of G418 for 2 weeks to select for transfected cells. The control cells formed 1-60 colonies per lung compared with 0-7 in the CL1-5/Naa10 group and 0-4 in the CL1-5/R82A group ( Figure S3C ). PCR analysis of humanspecific Alu element further supported these findings, in that the Naa10p and Naa10p-R82A groups had relatively few human cancer cells in the lungs compared with the control group ( Figure S3D ).
To further evaluate the role of Naa10p in metastasis, we used murine breast cancer cell line 4T1, which shows frequent lung metastasis after orthotopic fat pad inoculation. In order to avoid the effects of different sizes of primary tumors, we surgically removed fat pad tumors after the tumor size exceed 1 cm 3 . Mice were sacrificed after 2 weeks and lung metastases were examined by macroscopic observation and luciferase activity. Naa10p or Naa10p-R82A expression significantly diminished lung metastases ( Figures 3A and 3B) . Furthermore, axillary lymph node enlargements were found to be decreased in the Naa10p and Naa10p-R82A groups ( Figure 3C ). We also examined the presence of 4T1 cells in the peripheral blood and found significantly fewer cell numbers in the Naa10p and Naa10p-R82A groups ( Figure 3D ). We also examined the expression of Naa10p or Naa10p-R82A in colonies derived from either group to see if these colonies retained the expression of Naa10p or Naa10p-R82A. In all of the colonies, only four from the ten member Naa10p group and one from the nine member Naa10p-R82A group still expressed Naa10p/ Naa10p-R82A ( Figure S3E ). In order to examine lung colonization, lung adenocarcinoma cell line A549 was injected into the lateral tail vein of NOD-SCID mice. Six weeks postinjection, significantly lower metastatic nodules were formed in the A549/Naa10 group compared with the A549/vector group (Figure S3F) . Our data indicate that Naa10p expression suppresses tumor cell growth, extravasation, intravasation, and lung colonization.
Naa10p Alters the Activation Status of Cdc42 and Rac1
Rho family GTPases such as Rac1, Cdc42, and RhoA control actin dynamics and play key roles in cell migration. To determine whether the function of Naa10p in cell migration is mediated through the Rho family of GTPases, we compared the levels of GTP-bound RhoA, Rac1, and Cdc42 in the CL1-0 and CL1-5 cell lines. CL1-5 cells transfected with Naa10p or Naa10p-R82A resulted in lower levels of GTP-bound Rac1 and Cdc42 when compared with controls, while CL1-0 cells transfected with a siRNA pool directed against Naa10p resulted in higher levels of GTP-bound Rac1 and Cdc42 ( Figure 4A ). This result was further confirmed by using individual siRNA from the pool to knock down Naa10p and observed similar elevation of GTPbound Rac1 and Cdc42 ( Figure S4A ). To exclude the possibility of off-target effects, we reintroduced Naa10p in to the cells, bringing the GTP-bound Rac1 and Cdc42 level back to normal The cellular morphology is altered in cells with overexpressed or downregulated Naa10p expression. CL1-5 and AGS cells were transfected with either Naa10p-V5, Naa10p shRNA, or their respective controls, as indicated. Cells were fixed and stained for F-actin (green) and paxillin (red). Nuclei were counterstained with DAPI (blue). Scale bars, 20 mm.
(E) A549 cells were transfected with NATH-Myc, Naa10p-V5, and R82A-V5 either alone or in combination with each other, as indicated and subjected to transwell migration assay. The fold difference represents the mean of triplicate experiments compared with control cells. *p < 0.05. (F) CL1-5 cells were transfected with Naa10-V5 or Naa11-V5, and the transwell migration assay was performed. Each data point is representative as mean of triplicate experiments. *p < 0.05. (G) CL1-0 cells were infected with lentivirus carrying shRNA for either Naa10 or Naa11 and subjected to transwell migration assay. RT-PCR was performed using Naa10-or Naa11-specific primers. The fold difference represents the mean of triplicate experiments compared with control cells. *p < 0.05. Error bars indicate SD. See also Figure S2 .
( Figure S4B ). The levels of GTP-bound RhoA, however, remained unchanged. To elucidate the importance of decreased GTP-bound Rac1 and Cdc42 in Naa10p-regulated cell mobility, we expressed constitutively active Rac1 (Rac1 V12 ) and Cdc42
( Cdc42 V12 ) in CL1-5 cells with stable Naa10p expression. Both Rac1 V12 and Cdc42 V12 were found to be able to reverse the effect of Naa10p to bring the migration ability back to normal levels ( Figure 4B ). Furthermore, dominant negative Rac1 (
) and Cdc42 (Cdc42 N17 ) suppressed the migration ability induced by shRNA-mediated Naa10p knockdown in MCF-7 cells ( Figure 4C ). These data suggest that Naa10p regulation of cell migration depends on its ability to modulate Rac1 and Cdc42 activity.
Naa10p Interacts with bPIX
Our results suggest that Naa10p regulates cell mobility in an acetyltransferase-independent manner, possibly through the activation of Rac1 and Cdc42. However, we did not detect any direct association between Naa10p and Rac1 or Cdc42 (data not shown), which indicates that other binding partners such as GEFs or GAPs are required for Naa10p's regulation of Cdc42 and Rac1 activity.
To investigate the Naa10p-dependent regulation of Rac1 and Cdc42, we performed coimmunoprecipitation with V5-tagged Naa10p and known regulators of Rac1 and Cdc42 activity. We found that the PIX proteins (aPIX and bPIX) were able to bind to Naa10p. The PIX proteins are a group of GEFs known to regulate both Rac1 and Cdc42. In contrast, TIAM1, another GEF specific for Rac1/Cdc42, did not associate with Naa10p ( Figure 5A ). Previous studies have shown that aPIX is expressed primarily in hematopoietic cells and muscle, whereas bPIX is ubiquitously expressed (Koh et al., 2001; Manser et al., 1998) . In agreement with these findings, we detected the interaction between endogenous Naa10p and bPIX ( Figure 5B ) by coimmunoprecipitation. In addition, in vitro pull-down assays using recombinant GST-Naa10p (generated from Escherichia coli) and in vitro-transcribed/translated bPIX further suggested a direct association between Naa10p and bPIX ( Figure 5C ). A similar association occurred between Naa10p and aPIX ( Figure 5C ). Moreover, Naa11p and Naa15p failed to coimmunoprecipitate with aPIX or bPIX, implying a highly specific interaction between Naa10p and a/bPIX (Figures S5A and S5B) .
The Naa10p protein contains a conserved acetyltransferase domain. It was also reported that residues 1-58 in the N terminus were responsible for the Naa15p interaction, and that the last 50 residues in the C terminus mediated interaction with b-amyloid precursor protein (Asaumi et al., 2005) . To characterize the mechanism by which Naa10p and aPIX/bPIX interact, a series of expression constructs were generated for the wild-type fulllength and truncated mutants of Naa10p ( Figure 5D ). The aPIX and bPIX could be pulled down by full-length Naa10p, N-terminal deleted Naa10p (residues 59-235), and the Naa10p-acetyltransferase domain (residues 60-130), but not by C-terminal Naa10p (residues 131-235) ( Figure 5E ; Figure S5C ). These results indicate that the acetyltransferase domain is the primary site for aPIX and bPIX interaction.
To map the Naa10p binding region of bPIX, we used a series of bPIX truncation mutants ( Figure 5D ). Coimmunoprecipitation results revealed that all constructs with a GIT-binding domain (GBD) interacted with Naa10p ( Figure 5F ). This domain is conserved between aPIX and bPIX, and as expected, we found that Naa10p and aPIX interacted in the same fashion (Figure S5D) . Taken together, these results show that the Naa10p acetyltransferase domain interacts with the aPIX/bPIX GITbinding domain. We next examined whether bPIX was acetylated by Naa10p. Since their interaction was independent of Naa15p, bPIX was less likely to be N-a-acetylated by Naa10p. Naa10p has also been reported to function as an N-3-acetylatransferase (Lim et al., 2006 (Lim et al., , 2008 . Thus, we examined whether Naa10p mediated N-3-acetylation of bPIX. bPIX were immunoprecipitated from cells with Naa10p overexpression or knockdown by siRNA, and the acetylated bPIX was detected by antibodies against acetyl lysine. However, we could not detect any acetylated bPIX even with three different antibodies (Figure S5E) , indicating that Naa10p did not N-3-acetylated bPIX.
Naa10p Disrupts the Interaction with GIT to Inhibit Rac1/ Cdc42 Activation and Cell Migration Our results indicate that Naa10p regulates cellular migration through the interaction with PIX. To further explore this possibility, we transfected Naa10p either alone or in combination with bPIX in 293T cells. As expected, single transfection of bPIX resulted in increased Cdc42 and Rac1 activity. Interestingly dual transfection of Naa10p and bPIX only caused a modest increase of the activity compare to the untransfected control ( Figure 6A) . (A) CL1-5 and CL1-0 cells were transfected with Naa10-V5, R82A-V5, Naa10 siRNA, or their corresponding controls as indicated. GTP-Cdc42 and Rac1 were assayed using GST-PBD. GTP-RhoA was assayed using GST-TBD. Each experiment was repeated three times and the amounts of GTP-Cdc42/Rac1/RhoA were analyzed by densitometer. Figure S4 .
We also conducted single or dual transfection (as noted in Figure 6B ) in the highly migratory cell line CL1-5. Interestingly, individual transfection of GIT1, aPIX, or bPIX was sufficient to increase cell migration, while single transfection of Naa10p resulted in a significant decrease of cell migration. In consistence with the above findings, dual transfection of Naa10p in combination with GIT1, aPIX or bPIX resulted in similar migration compared with the untransfected control ( Figure 6B ). Hence overexpression of Naa10p is sufficient to prevent PIX dependent activation of Cdc/Rac activity and cell migration.
Similary, knockdown of bPIX alone was sufficient to suppress Rac1 and Cdc42 activity and inhibited cell migration and the metastatic ability of CL1-5 cells ( Figures S6A, S7A , and S7D-S7G). Furthermore, overexpression of aPIX or bPIX increased the migration ability of CL1-0 cells ( Figure S7B ). Consistently, shRNA specific for aPIX or bPIX decreased the migration ability of Naa10p knockdown AGS cells ( Figure 6C ). These data suggested that aPIX and/or bPIX are important for Naa10p to regulate small G protein activity and cell migration.
Previous studies have shown that GIT proteins are involved in guiding PIX proteins to the cell periphery or focal adhesions where they activate Rac1 or Cdc42 (Koh et al., 2001) . In order to evaluate the importance of GIT proteins in our cell model, we used shRNAs to knock down GIT1 and GIT2 separately and estimated the levels of GTP-bound Rac1/Cdc42. Both GIT1 and GIT2 were expressed in CL1-5 cells and affected the GTP-bound level of Rac1/Cdc42 and cell migration when diminished by shRNAs. Furthermore, simultaneous knockdown of both GITs further suppresses the activity of Rac1/Cdc42 (Figure S6B) and cell migration to a more significant level ( Figure S7C , p < 0.005). These results suggest that both GIT1 and GIT2 promote Rac1/Cdc42 activation and cell migration in CL1-5 cells. Since Naa10p binds to the GIT-binding domain of PIX proteins, we evaluated whether Naa10p could disrupt the association between aPIX or bPIX and GIT proteins. Our results indicated that the ability of GST-bPIX to associate with Flagtagged GIT1 and GIT2 was decreased in the presence of V5-tagged Naa10p ( Figure 6D ) or Naa10p-R82A ( Figure S6C) . However, the ability of GST-bPIX to associate with HA-tagged PAK1 or PAK3, which interacts with the SH3 domain of the PIX proteins, was not changed in the presence of Naa10p or Naa10p-R82A ( Figure S6D ). Moreover, GST-Naa10p lost its ability to associate with Myc-tagged aPIX in the presence of Flag-tagged GIT1 ( Figure S6E ). Consistent with these findings, the amount of bPIX-associated GIT1 was higher in low Naa10p-expressing CL1-5 cells compared with the high Naa10p-expressing CL1-0 cells ( Figure 6E ). This competition could also be observed in the cell migration ability, where overexpression of Flag-tagged GIT1, but not the Myc-tagged PAK1, increased the migration ability of Naa10p-overexpressing CL1-5 cells ( Figure 6B ). Similarly, shRNA specific for GIT1 reduced the migration ability of Naa10p knockdown AGS cells ( Figure 6C ). To determine whether Naa10p could influence the localization of aPIX and bPIX, we evaluated the distribution of endogenous bPIX by immunofluorescence staining analysis. bPIX was detected in the puncta of membrane protrusions in A549 cells, but was dramatically decreased in cells with Naa10p-V5 expression ( Figure 6F ). Furthermore, transfection of shRNAs against aPIX or bPIX in Naa10p-knockdown AGS cells resulted in a less protrusive phenotype. Ectopic overexpression of aPIX or bPIX in CL1-5/Naa10 cells resulted in a more protrusive phenotype, similar to that observed in the CL1-5 control cells (Figure S6G) . We also noted a slight decrease of bPIX in the membrane fraction of CL1-5/Naa10 cells ( Figure 6G ). Similarly, a substantial portion of bPIX was detected in the membrane fraction of CL1-0 cells when Naa10p was depleted ( Figure S6F ). These data suggest that Naa10p competes against GIT for binding to PIX, preventing the translocation of PIX to the plasma membrane. This results in decreased Rac1/Cdc42 activation and decreased cell mobility.
To elucidate the role of Naa10p and PIX proteins in metastasis, we generated GFP-and luciferase-expressing CL1-5 cells (CL1-5GL) and transfected them with an empty vector, Naa10p-V5 alone, or in combination with aPIX or bPIX (Figure 7A ). Cells were injected into the tail vein of NOD-SCID mice and the mice were monitored for the formation of lung tumors. Four weeks after injection, the number of lung metastatic nodules was determined by bioluminescence activity. Large numbers of metastatic nodules were observed in animals injected with control CL1-5GL cells, whereas few nodules were 
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As predicted, overexpression of aPIX or bPIX increased the number of metastatic nodules in ARD-V5-expressing CL1-5GL cells ( Figure 7B ). Quantitative data (the number of surface lung metastases and level of photon radiance), shown in Figures 7C and 7D, confirmed these findings. Together this indicates that the Naa10p-mediated regulation of PIX proteins is an important event in the formation of lung metastasis.
DISCUSSION
Tumor metastasis is the main cause of cancer-related death.
Identifying genes regulating cell migration and metastasis is crucial to the understanding of this process. In recent years, the Rac1 and Cdc42 pathways have been extensively studied in the context of metastasis. The complex interplay between its regulators and effectors results in the establishment of membrane protrusions and eventual cell migration. The PIX family of proteins has an important function in this process, acting as a GEF and scaffold protein between Rac1/Cdc42 and their effectors. We have identified Naa10p as a regulator of PIX and suppressor of tumor cell migration and/or metastasis. We found that Naa10p and GIT bind to the same site of the PIX protein.
In the presence of Naa10p, GIT proteins fail to bind to the PIX proteins, disrupting the translocation of PIX to the plasma membrane ( Figure 7E ). Therefore, high expression of Naa10p restricts cell mobility and decreases the possibility of cancer cell metastasis in vivo. Recently, Lee et al. have used Naa10p antibody to analyze a small cohort of lung adenocarcinoma and observed (C) Cell migration of AGS cells infected with lentivirus carrying shRNA for either Naa10p or luciferase, or together with shRNA for aPIX, bPIX, or GIT1. The percentage of migrated cells compared with cells receiving shRNA for luciferase is shown. The knockdown efficiency was shown by western blot analysis using specific antibodies. *p < 0.05. (D) 293T cell lysates containing Flag-GIT1, Flag-GIT2, or Naa10-V5 were incubated with either GST or GST-bPIX as indicated. Left panel: Pull-down products were washed and subjected to SDS-PAGE. GIT1, GIT2, and Naa10p were detected by immunoblotting using specific antibodies. Right panel: 10% loading input for each group. (E) bPIX-associated GIT1 were examined in CL1-0 and CL1-5 cells. Cell lysates were immunoprecipitated with anti-bPIX and immunoblotted with anti-GIT1 antibody. (F) Representative photographs for immunofluorescence staining of endogenous bPIX in A549 cells stably expressing Naa10-V5 or control vector. Arrows indicate bPIX-enriched cell protrusions. Nuclei were counterstained with DAPI. Scale bar, 10 mm. (G) Subcellular fractionation was performed with the CNM compartmental protein extraction kit (K3012010, BioChain Institute, Inc., Hayward, CA). The subcellular distribution of Naa10p and bPIX was determined by immunoblotting. EGFR was used as the membrane marker, and a-Tubulin was used as the cytosolic marker. M, membrane fraction; C, cytosolic fraction. Error bars indicate SD. See also Figure S6 . (A) Establishment of CL1-5/luciferase cells stably expressing Naa10-V5 and Naa10-V5 plus aPIX or bPIX. Expression of Naa10p was detected using a chicken anti-Naa10p polyclonal antibody (ab51787, Abcam). aPIX and bPIX were detected using a rabbit anti-PIX polyclonal antibody (AB3829, Chemicon). a correlation between Naa10p expression and patient survival . However, since Naa10p is known to have several variants and homolog (Bilton et al., 2006) , it is possible that Lee's antibody raised against full-length Naa10p may also recognize these Naa10p family proteins due to their highly conserved acetyltransferse motif. Here, we used a specific antibody which recognizes the C-terminal region of Naa10p (aa 155-235) to analyze 318 lung tumor specimens and found a reverse correlation with patient overall survival (p = 0.0044) and disease-free survival (p = 0.0039). We have also observed a significant inverse correlation of Naa10p expression and patient survival in female adenocarcinoma population. However, Naa10p expressions are not significantly correlates with patient survival of male or SCC patients ( Figures S1C and S1D ). The inconsistent results may be due to the antibody specificity and/or the different compositions of patient cohorts. Collectively, our results based on specific antibody and multiple lines of clinical evidence support that Naa10p is a suppressor of tumor progression. N-a-acetylation is one of the most common post-translational modifications in eukaryotes. The major N-a-acetyltransferase in human cells is composed of Naa10p and Naa15p (Polevoda and Sherman, 2000) . There have also been reports indicating that Naa10p can function as an N-3-acetyltransferase (Lim et al., 2006 (Lim et al., , 2008 . However, it remains questionable as to whether one enzyme could catalyze both N-a-and N-3-acetylation. Here, we report that Naa10p can exert its function independent of its enzymatic activity. We found that Naa10p suppressed cell migration in the absence of Naa15p. Unlike Naa10p depletion by siRNAs or shRNA, Naa15p depletion by shRNA specific for Naa15p did not affect cell migration (data not shown). Furthermore, a Naa10p mutant without acetyl-CoA binding ability retained its migration inhibiting capability. We propose that Naa10p regulates cell migration by interacting with the PIX family of proteins. Although the interaction with PIX occurs with the acetyltransferase domain of Naa10p, we did not observe any detectable level of acetylated bPIX in cells under the influence of Naa10p-V5 or in the presence of specific shRNA against it, indicating that bPIX may not be an N-3-acetylation target of Naa10p.
Our data suggest that Naa10p regulates cell migration through the Rac1/Cdc42 pathway. PIX is a well-studied regulator as a GEF of both Rac1 and Cdc42. Our current hypothesis is that Naa10p binds and regulates the cellular localization of PIX thereby preventing the activation of Rac1/Cdc42. In addition to acting as a GEF, PIX can function as scaffold protein within the focal adhesion complex. Previous studies have shown that PAK, the major component of the Rac1/Cdc42 pathway can bind to the SH3 domain of PIX (Manser et al., 1998) . Hence, PIX does not only activate PAK, it plays a central role in bringing PAK to the focal adhesion complex. Interestingly, PIX has been shown to activate PAK independently of Rac1/Cdc42 activity, possibly through the interaction of the other members of the focal adhesion complex. In addition to PAK, PIX can associate with GIT, another scaffold protein of the focal adhesion complex. GIT function as the link between paxillin and the PIX complex (Zhao et al., 2000) . The GIT family consists of two highly similar proteins: GIT1 and GIT2 (Premont et al., 1998 (Premont et al., , 2000 . Both bind directly to paxillin, and thereby localized to focal adhesions. Our result indicates that both GIT proteins may be involved in Rac1/Cdc42 activation and cell migration potentials in a similar manner, as the depletions of both GIT1 and GIT2 suppress GTPase activation and reduces cell migration more significantly than depletion of either one alone ( Figure S6B ). The underlying mechanism is speculated to be that GIT1 and GIT2 could substitute for each other in directing PIX proteins to focal adhesions through interaction with paxillin. Upon depletion of one GIT proteins, the other one is still capable of directing localization of PIX proteins. We propose that Naa10p competes with GIT for the binding of PIX. Since this interaction is required to bring PIX to the focal adhesion, overexpression of Naa10p reduces the amount of PIX at the cellular membrane ( Figures 6F and  6G) , prevents the activation of Cdc42/Rac ( Figure 4A ) and decrease cell migration.
Although our data suggest GBD domain is the primary site for Naa10p interaction, the other domains or other PIX-associated protein may also affect the interaction between Naa10p and PIX. Given that PH domain-deleted bPIX showed a reduced affinity to Naa10p ( Figure 5F ), it is possible that proteins associated with PH domain may help providing proper structure for Naa10p docking at the GBD domain. Similar situations may occur at other domains, since SH3 and LZ domain deletion also seems to affect the interaction between aPIX and Naa10p ( Figure S5D ). However, our results suggest that Naa10p binding only affects the interaction between GIT1/2 and PIX but not PAK1/3, which interacts with PIX at the SH3 domain. This observation supports that the GBD domain was the major site, even not the only site, for the Naa10p interaction.
The role of Naa10p in cell migration is likely to be complex. Although our study indicates an acetylation-independent mechanism of Naa10p in regulating cell mobility, we cannot rule out the acetylation-dependent mechanism. As shown in Figure S2F , the Naa10p-R82A mutant may still have some remaining function to acetylate some other specific proteins that participate in cell mobility control. Recently, myosin light chain kinase (MLCK) was found to be another Naa10p target (Shin et al., 2009 ). Naa10p acetylated MLCK and suppressed its activity, which resulted in decreased cell mobility. Interestingly, myosin light chain is one of the targets of the PAKs (Chew et al., 1998; Coniglio et al., 2008) , which suggests a possible involvement of the PIX-GIT-Paxillin complex in this process. PAKs could either be directly activated by Rac1 and Cdc42 binding (Knaus et al., 1998) or induced by GIT-PIX-PAK complex formation (Loo et al., 2004) . Our data suggest that both of these processes can be suppressed by Naa10p. A study by Shin et al. (2009) and our findings emphasize the importance of Naa10p as an important regulator of cell migration and metastasis.
Naa10p was found to express in tumor tissues. However, the role of Naa10p in tumorigenesis is controversy. Although growth-promoting activity associated with Naa10p function is well in line with published evidence, there is also report suggested that different Naa10 siRNAs used may result in complete opposite effect (Yi et al., 2007) . Lee et al. reported that Naa10p promotes tumorigenesis in lung cancer cells, and suggest that Naa10p is helping the DNMT to silence tumor suppressors. However, Naa10p maybe act through different mechanism in normal epithelium and tumor cells. Recently, Naa10p has been shown to suppress tumorigenesis through acteylating TSC2 and induce autophagy of tumor cell (Kuo et al., 2010) . Kuo et al. and our in vivo results had also shown significant smaller tumor size of xenografts in Naa10p overexpression cells (Figure S3A ). In line with our clinical results (Table 1) , Kuo et al. had also observed a significant lower Naa10p expression in breast cancer specimens and lymph node metastases. Although the exact roles of Naa10p in tumorigenesis and/or tumor progression remain to be elucidated, we showed here that Naa10p act as a metastasis suppressor during tumor progression.
In conclusion, we have shown that Naa10p is a good prognostic factor whose overexpression is associated with increased survival and decreased lymph node metastasis. We propose that Naa10p can act as a tumor migration and/or metastasis suppressor by binding to the GIT binding domain of PIX. Our data indicate that Naa10p has the opposite effect of GIT to prevent membrane protrusion, cell migration, and lymph node metastasis.
EXPERIMENTAL PROCEDURES Immunohistochemistry
Tissues utilized were obtained with informed consent and the study was conducted under the approval of the Institutional Review Boards of National Taiwan University Hospital and Kaohsiung Medical University Hospital. Tissue was fixed in formalin and subsequently was dehydrated, paraffin embedded, and sectioned. Tissue sections were immunostained as described previously (Su et al., 2004) . A four-point staining intensity scoring system was devised for determining the relative expression of Naa10p in cancer specimens; the staining intensity score ranged from 0 (no expression) to 3 (maximal expression). The results were classified into two groups according to both the intensity and extent of staining: in the low-expression group, either no staining was present (staining intensity score = 0) or positive staining was detected in less than 10% of the cells (staining intensity score = 1), and in the high-expression group, positive immunostaining was present in 10%-25% (staining intensity score = 2) or more than 25% of the cells (staining intensity score = 3). All of the immunostaining results were reviewed and scored independently by two pathologists. The histological diagnosis of lung adenocarcinoma was made according to the recommendations of the World Health Organization (Gibbs and Thunnissen, 2001) . Tumor size, local invasion, lymph node metastasis, and final disease stage were determined as described previously (Sobin and Fleming, 1997) . Follow-up of patients was carried out up to 200 months.
siRNA Transfection On-Target plus siRNAs for human Naa10p, as well as Risc-free control siRNA, were from Dharmacon Research (Lafayette, CO). Cells were transfected with siRNAs as indicated for 18-24 hr using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) followed by a change of media. Two to three days after siRNA transfection, cells were subjected to migration assays. Reduced expression by siRNA was monitored by immunoblotting with Naa10p antibody.
Two-Chamber Migration Assay
Cell mobility was determined using the modified two-chamber migration assay (8 mm pore size, BD Biosciences, Bedford, MA) according to the manufacturer's instructions. About 2 3 10 4 cells were seeded into the upper chamber and allowed to migrate into the lower chamber for 18-24 hr. Cells in the upper chamber were carefully removed using cotton buds and cells at the bottom of the membrane were fixed and stained with crystal violet 0.2%/methanol 20%. Quantification was performed by counting the stained cells.
Immunofluorescence Microscopy
Cells were grown on coverslips and fixed in 4% paraformaldehyde, permeabilized, and stained with primary antibodies followed by secondary FITC or Alexa 555-conjugated mouse or rabbit antibodies. F-actin was detected with FITC-phalloidin (Invitrogen). Slides were examined and photographed using a Zeiss Axiophot fluorescence microscope. Nuclei were counterstained with 4 0 ,6-diamino-2-phenylindole (DAPI).
Immunoprecipitation
Cells were lysed by brief sonication (3 3 1 s pulses) in coimmunoprecipitation buffer (20 mM Tris [pH 8.0], 150 mM NaCl, 1 mM EDTA, 0.5% NP-40 supplemented with protease [Complete, Roche] inhibitors). Lysates were centrifuged for 20 min at 10,000 3 g and the resulting supernatant was precleared by incubation with immobilized Protein A/G gel (25 ml; Pierce, Rockford, IL) for 1 hr at 4 C. The precleared supernatant was subjected to overnight immunoprecipitation using the indicated antibodies or control IgG antibodies at 4 C. The next day, protein complexes were collected by incubation with 25 ml of immobilized Protein A/G gel for 1 hr at 4 C. The collected protein complexes were washed four times with coimmunoprecipitation buffer and eluted by boiling in protein sample buffer under reducing conditions, after which proteins were resolved on SDS-PAGE and analyzed by western blot.
Spontaneous Metastasis Assay
Seven female BALB/c mice were fat pad injected with 4T1/Luc cells overexpressing Naa10p, Naa10p-R82A, or control vector (1 310 5 cells with Matrigel at 5 mg ml -1 of PBS in a volume of 200 ml). Tumor growth was monitored twice a week by Vernier caliper measurement of two perpendicular tumor diameters (L and W). Tumor volume was calculated using the formula LW 2 /2. After the tumor volume exceeded 1 cm 3 , the primary tumors were surgically removed.
Lungs were isolated 2 weeks after the surgery and examined. The tumor colonies were counted 3 weeks later. All animal work was performed in accordance with protocols approved by the Institutional Animal Care and Use Committee of the College of Medicine, National Taiwan University.
Statistical Analysis
Results are expressed as the mean ± SD. We utilized a two-tailed, unpaired Student's t test for all pair-wise comparisons. Survival curves were obtained using the Kaplan-Meier method. p values less than 0.05 were considered significant.
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